2024-12-25 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**1. Performance Comparison & Overview:**

Intuitive Surgical Inc. is a leading manufacturer and marketer of da Vinci surgical systems.  The cumulative return of ISRG (286.89%) significantly outperforms the S&P 500 (VOO) cumulative return of 117.56% over the analyzed period. The difference is 169.3%, placing it in the 90.2nd percentile of its historical relative performance against the S&P 500.  The provided alpha consistently shows 0.0, indicating the stock's return is solely explained by its beta,  a measure of its volatility relative to the market.  Beta values range from 43 to 188. This high beta suggests substantial market sensitivity.

**2. Recent Price Movement:**

* **Closing Price:** $527.22
* **Last Market Price:** $537.02
* **5-Day Moving Average:** $529.44
* **20-Day Moving Average:** $539.29
* **60-Day Moving Average:** $519.44

The current price ($537.02) is slightly above the 5-day moving average but below the 20-day and 60-day moving averages, suggesting a recent pullback from a higher price point.


**3. Technical Indicators and Expected Return:**

* **RSI (Relative Strength Index):** 39.27 – Indicates the stock is currently in oversold territory, suggesting potential for a price bounce.
* **PPO (Percentage Price Oscillator):** -0.65 – Suggests bearish momentum.
* **Recent Relative Strength Change (20-day):** -3.3% – Shows a recent weakening in relative strength.
* **Expected Return (Long-Term):** 113.5% –  Significantly higher than the market,  suggesting strong potential for outperformance over the long term (2+ years) assuming historical trends continue. However, this is a forecast based on past performance which may not hold true for future periods.

The difference between the Last Market price and Closing Price suggests a recent upward movement, but the technical indicators point towards a relatively weak short-term outlook.  The high expected return is a key bullish signal.

**4. Recent Earnings Analysis:**

The recent quarterly earnings show:

* **Revenue:**  Steady growth in revenue is evident, peaking at $2.04B in the quarter ending September 2024.
* **EPS:** EPS has fluctuated slightly, with a slight decline seen in the quarter ending October 2023. This indicates some variability in profitability.
* **Comparison:** The data shows consistent revenue growth but lacks the context of whether these results surpassed or missed market expectations.


**5. Financial Information Analysis:**

The financial data reveals:

* **Revenue:**  Shows a consistent growth pattern, peaking at $2.04B in Q3 2024.
* **Profit Margin:** The profit margin has remained relatively stable and high, ranging from 65.87% to 68.30% in the last four quarters. This showcases strong profitability.
* **Equity:** The company's equity is consistently growing.
* **ROE (Return on Equity):** While there is some fluctuation, the ROE generally indicates acceptable profitability given the company’s growth.


**6. News and Recent Issues:**

*The report does not provide any specific recent news or market outlook information. Analyst opinions and performance highlights are needed for a comprehensive analysis.*  More information is required in this section.

**7. Overall Analysis:**

ISRG has shown exceptional long-term outperformance compared to the S&P 500.  While recent short-term indicators (RSI, PPO, and the 20-day relative strength) suggest some weakness, the long-term outlook remains bullish, supported by a high expected return and consistent revenue and profit margin growth.  However,  this analysis lacks crucial information regarding recent news, market outlook, and comparison of actual results against analyst expectations.  The high beta suggests significant volatility, which investors should consider.  Further investigation into recent news and analyst opinions is essential before making any investment decisions.

**8. Disclaimer:** This analysis is based solely on the provided data and does not constitute financial advice.  Investing in the stock market carries inherent risk, and past performance is not indicative of future results.  Conduct thorough independent research before making any investment decisions.
